Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001564590-21-022243
Filing Date
2021-04-30
Accepted
2021-04-30 08:58:59
Documents
8
Period of Report
2021-04-30

Document Format Files

Seq Description Document Type Size
1 6-K bntx-6k_20210430.htm 6-K 17997
2 EX-99.1 bntx-ex991_6.htm EX-99.1 40483
3 GRAPHIC gdtodyoqoyfd000002.jpg GRAPHIC 41593
4 GRAPHIC gl04fjvuohx1000002.jpg GRAPHIC 804
5 GRAPHIC gl04fjvuohx1000004.jpg GRAPHIC 804
6 GRAPHIC gdtodyoqoyfd000001.jpg GRAPHIC 92558
7 GRAPHIC gl04fjvuohx1000003.jpg GRAPHIC 804
8 GRAPHIC gl04fjvuohx1000001.jpg GRAPHIC 804
  Complete submission text file 0001564590-21-022243.txt   249458
Mailing Address AN DER GOLDGRUBE 12 MAINZ 2M 55131
Business Address AN DER GOLDGRUBE 12 MAINZ 2M 55131 0049613190847081
BioNTech SE (Filer) CIK: 0001776985 (see all company filings)

EIN.: 000000000 | State of Incorp.: 2M | Fiscal Year End: 1231
Type: 6-K | Act: 34 | File No.: 001-39081 | Film No.: 21874039
SIC: 2836 Biological Products, (No Diagnostic Substances)